Saxon covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Cooper Co, and NuVasive. According to TipRanks, Saxon has an average return of -17.2% and a 17.39% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for RxSight with a $20.33 average price target, representing a 61.09% upside. In a report released yesterday, BTIG also reiterated a Buy rating on the stock with a $24.00 price target.
RXST market cap is currently $348.7M and has a P/E ratio of -5.05.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
Read More on RXST: